Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $1.19 Million - $1.55 Million
5,786 Added 183.92%
8,932 $1.85 Million
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $640,273 - $860,210
3,146 New
3,146 $852,000
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $110,226 - $126,150
600 Added 55.92%
1,673 $351,000
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $205,897 - $278,894
1,073 New
1,073 $216,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $221,664 - $304,406
1,215 Added 57.97%
3,311 $652,000
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $471,948 - $699,148
-2,312 Reduced 52.45%
2,096 $449,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $3.17 Million - $4.5 Million
-12,415 Reduced 73.8%
4,408 $1.25 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $8.73 Million - $11.1 Million
-24,850 Reduced 59.63%
16,823 $6.34 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $15.5 Million - $19.1 Million
41,669 Added 1041725.0%
41,673 $17.2 Million
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $3.76 Million - $4.75 Million
-12,794 Reduced 99.97%
4 $1,000
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $1.53 Million - $1.84 Million
6,136 Added 92.1%
12,798 $3.71 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $1.25 Million - $1.42 Million
5,619 Added 538.73%
6,662 $1.67 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $1.59 Million - $2.54 Million
-13,372 Reduced 92.76%
1,043 $182,000
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $145,679 - $262,694
1,473 Added 11.38%
14,415 $1.82 Million
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $1.48 Million - $1.8 Million
11,753 Added 988.48%
12,942 $1.98 Million
Q3 2019

Nov 08, 2019

SELL
$125.07 - $143.67 $1.1 Million - $1.27 Million
-8,829 Reduced 88.13%
1,189 $157,000
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $198,180 - $238,571
-1,606 Reduced 13.82%
10,018 $1.42 Million
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $1.08 Million - $1.51 Million
10,319 Added 790.73%
11,624 $1.69 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $137,142 - $179,085
1,305 New
1,305 $148,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.55B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.